* German pharmaceutical company Bayer has had an appeal against an August 2020 reform to Mexico’s acquisitions law accepted. The reform passed last year allows the Mexican government to purchase health related goods and services abroad through the United Nations Office for Project Services (Unops), part of efforts to respond to the shortage of certain medicines. But Bayer argues that this reform to the law on acquisition, leases, and services in the public sector is unconstitutional as it violates competition provisions and affects consumers. Bayer’s appeal has been admitted by the fourth district court for administrative matters in Mexico City, according to court documents seen by Spanish newswire
EFE. The preliminary proceedings are set to take place on 28 June, followed by a constitutional hearing 4 August.
End of preview - This article contains approximately 126 words.
Subscribers: Log in now to read the full article
Not a Subscriber?
Choose from one of the following options